# TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study

> **NCT01657604** · PHASE3 · COMPLETED · sponsor: **University of Jena** · enrollment: 717 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Peginterferon α2b
- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT01657604
- **Lead sponsor:** University of Jena
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-24
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 717 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657604, "TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01657604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*